Global Radiopharmaceutical Market Research Report 2022

Global Radiopharmaceutical Market Research Report 2022

Table of Contents
1 Radiopharmaceutical Market Overview
1.1 Product Overview and Scope of Radiopharmaceutical
1.2 Radiopharmaceutical Segment by Type
1.2.1 Global Radiopharmaceutical Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Radiopharmaceutical Segment by Application
1.3.1 Global Radiopharmaceutical Sales Comparison by Application: (2022-2028)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceutical Revenue 2017-2028
1.4.2 Global Radiopharmaceutical Sales 2017-2028
1.4.3 Radiopharmaceutical Market Size by Region: 2017 Versus 2021 Versus 2028
2 Radiopharmaceutical Market Competition by Manufacturers
2.1 Global Radiopharmaceutical Sales Market Share by Manufacturers (2017-2022)
2.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Radiopharmaceutical Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Radiopharmaceutical Manufacturing Sites, Area Served, Product Type
2.5 Radiopharmaceutical Market Competitive Situation and Trends
2.5.1 Radiopharmaceutical Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Radiopharmaceutical Players Market Share by Revenue
2.5.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Radiopharmaceutical Retrospective Market Scenario by Region
3.1 Global Radiopharmaceutical Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Radiopharmaceutical Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Radiopharmaceutical Market Facts & Figures by Country
3.3.1 North America Radiopharmaceutical Sales by Country
3.3.2 North America Radiopharmaceutical Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Radiopharmaceutical Market Facts & Figures by Country
3.4.1 Europe Radiopharmaceutical Sales by Country
3.4.2 Europe Radiopharmaceutical Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Radiopharmaceutical Market Facts & Figures by Region
3.5.1 Asia Pacific Radiopharmaceutical Sales by Region
3.5.2 Asia Pacific Radiopharmaceutical Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Radiopharmaceutical Market Facts & Figures by Country
3.6.1 Latin America Radiopharmaceutical Sales by Country
3.6.2 Latin America Radiopharmaceutical Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Radiopharmaceutical Market Facts & Figures by Country
3.7.1 Middle East and Africa Radiopharmaceutical Sales by Country
3.7.2 Middle East and Africa Radiopharmaceutical Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Radiopharmaceutical Historic Market Analysis by Type
4.1 Global Radiopharmaceutical Sales Market Share by Type (2017-2022)
4.2 Global Radiopharmaceutical Revenue Market Share by Type (2017-2022)
4.3 Global Radiopharmaceutical Price by Type (2017-2022)
5 Global Radiopharmaceutical Historic Market Analysis by Application
5.1 Global Radiopharmaceutical Sales Market Share by Application (2017-2022)
5.2 Global Radiopharmaceutical Revenue Market Share by Application (2017-2022)
5.3 Global Radiopharmaceutical Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporation Information
6.1.2 Bracco Imaging Description and Business Overview
6.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
6.1.5 Bracco Imaging Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Bayer Radiopharmaceutical Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Nordion
6.4.1 Nordion Corporation Information
6.4.2 Nordion Description and Business Overview
6.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Nordion Radiopharmaceutical Product Portfolio
6.4.5 Nordion Recent Developments/Updates
6.5 Triad Isotopes
6.5.1 Triad Isotopes Corporation Information
6.5.2 Triad Isotopes Description and Business Overview
6.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
6.5.5 Triad Isotopes Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Lantheus Radiopharmaceutical Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 IBA Group
6.6.1 IBA Group Corporation Information
6.6.2 IBA Group Description and Business Overview
6.6.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.4.4 IBA Group Radiopharmaceutical Product Portfolio
6.7.5 IBA Group Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Corporation Information
6.9.2 China Isotope & Radiation Description and Business Overview
6.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
6.9.5 China Isotope & Radiation Recent Developments/Updates
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Corporation Information
6.10.2 Jubilant Pharma Description and Business Overview
6.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
6.10.5 Jubilant Pharma Recent Developments/Updates
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Radiopharmaceutical Description and Business Overview
6.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
6.11.5 Eli Lilly Recent Developments/Updates
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Corporation Information
6.12.2 Advanced Accelerator Applications Radiopharmaceutical Description and Business Overview
6.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
6.12.5 Advanced Accelerator Applications Recent Developments/Updates
6.13 SIEMENS
6.13.1 SIEMENS Corporation Information
6.13.2 SIEMENS Radiopharmaceutical Description and Business Overview
6.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.13.4 SIEMENS Radiopharmaceutical Product Portfolio
6.13.5 SIEMENS Recent Developments/Updates
6.14 Dongcheng
6.14.1 Dongcheng Corporation Information
6.14.2 Dongcheng Radiopharmaceutical Description and Business Overview
6.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Dongcheng Radiopharmaceutical Product Portfolio
6.14.5 Dongcheng Recent Developments/Updates
6.15 Navidea
6.15.1 Navidea Corporation Information
6.15.2 Navidea Radiopharmaceutical Description and Business Overview
6.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Navidea Radiopharmaceutical Product Portfolio
6.15.5 Navidea Recent Developments/Updates
7 Radiopharmaceutical Manufacturing Cost Analysis
7.1 Radiopharmaceutical Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Radiopharmaceutical
7.4 Radiopharmaceutical Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Radiopharmaceutical Distributors List
8.3 Radiopharmaceutical Customers
9 Radiopharmaceutical Market Dynamics
9.1 Radiopharmaceutical Industry Trends
9.2 Radiopharmaceutical Market Drivers
9.3 Radiopharmaceutical Market Challenges
9.4 Radiopharmaceutical Market Restraints
10 Global Market Forecast
10.1 Radiopharmaceutical Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Radiopharmaceutical by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Radiopharmaceutical by Type (2023-2028)
10.2 Radiopharmaceutical Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Radiopharmaceutical by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Radiopharmaceutical by Application (2023-2028)
10.3 Radiopharmaceutical Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Radiopharmaceutical by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Radiopharmaceutical by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Radiopharmaceutical Sales Growth Rate Comparison by Type (2022-2028) & (M Doses) & (US$ Million)
Table 2. Global Radiopharmaceutical Sales Growth Rate Comparison by Application (2022-2028) & (M Doses) & (US$ Million)
Table 3. Global Radiopharmaceutical Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Radiopharmaceutical Market Competitive Situation by Manufacturers in 2021
Table 5. Global Radiopharmaceutical Sales (M Doses) of Key Manufacturers (2017-2022)
Table 6. Global Radiopharmaceutical Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Radiopharmaceutical Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Radiopharmaceutical Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Radiopharmaceutical Average Price (USD/Dose) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Radiopharmaceutical Manufacturing Sites and Area Served
Table 11. Manufacturers Radiopharmaceutical Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceutical as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Radiopharmaceutical Sales by Region (2017-2022) & (M Doses)
Table 16. Global Radiopharmaceutical Sales Market Share by Region (2017-2022)
Table 17. Global Radiopharmaceutical Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Radiopharmaceutical Revenue Market Share by Region (2017-2022)
Table 19. North America Radiopharmaceutical Sales by Country (2017-2022) & (M Doses)
Table 20. North America Radiopharmaceutical Sales Market Share by Country (2017-2022)
Table 21. North America Radiopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Radiopharmaceutical Revenue Market Share by Country (2017-2022)
Table 23. Europe Radiopharmaceutical Sales by Country (2017-2022) & (M Doses)
Table 24. Europe Radiopharmaceutical Sales Market Share by Country (2017-2022)
Table 25. Europe Radiopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Radiopharmaceutical Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Radiopharmaceutical Sales by Region (2017-2022) & (M Doses)
Table 28. Asia Pacific Radiopharmaceutical Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Radiopharmaceutical Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Radiopharmaceutical Revenue Market Share by Region (2017-2022)
Table 31. Latin America Radiopharmaceutical Sales by Country (2017-2022) & (M Doses)
Table 32. Latin America Radiopharmaceutical Sales Market Share by Country (2017-2022)
Table 33. Latin America Radiopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Radiopharmaceutical Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Radiopharmaceutical Sales by Country (2017-2022) & (M Doses)
Table 36. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Radiopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Radiopharmaceutical Revenue Market Share by Country (2017-2022)
Table 39. Global Radiopharmaceutical Sales by Type (2017-2022) & (M Doses)
Table 40. Global Radiopharmaceutical Sales Market Share by Type (2017-2022)
Table 41. Global Radiopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Radiopharmaceutical Revenue Share by Type (2017-2022)
Table 43. Global Radiopharmaceutical Price by Type (2017-2022) & (USD/Dose)
Table 44. Global Radiopharmaceutical Sales (M Doses) by Application (2017-2022)
Table 45. Global Radiopharmaceutical Sales Market Share by Application (2017-2022)
Table 46. Global Radiopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Radiopharmaceutical Revenue Share by Application (2017-2022)
Table 48. Global Radiopharmaceutical Price by Application (2017-2022) & (USD/Dose)
Table 49. Bracco Imaging Corporation Information
Table 50. Bracco Imaging Description and Business Overview
Table 51. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 52. Bracco Imaging Radiopharmaceutical Product
Table 53. Bracco Imaging Recent Developments/Updates
Table 54. Bayer Corporation Information
Table 55. Bayer Description and Business Overview
Table 56. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 57. Bayer Radiopharmaceutical Product
Table 58. Bayer Recent Developments/Updates
Table 59. Mallinckrodt Corporation Information
Table 60. Mallinckrodt Description and Business Overview
Table 61. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 62. Mallinckrodt Radiopharmaceutical Product
Table 63. Mallinckrodt Recent Developments/Updates
Table 64. Nordion Corporation Information
Table 65. Nordion Description and Business Overview
Table 66. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 67. Nordion Radiopharmaceutical Product
Table 68. Nordion Recent Developments/Updates
Table 69. Triad Isotopes Corporation Information
Table 70. Triad Isotopes Description and Business Overview
Table 71. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 72. Triad Isotopes Radiopharmaceutical Product
Table 73. Triad Isotopes Recent Developments/Updates
Table 74. Lantheus Corporation Information
Table 75. Lantheus Description and Business Overview
Table 76. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 77. Lantheus Radiopharmaceutical Product
Table 78. Lantheus Recent Developments/Updates
Table 79. IBA Group Corporation Information
Table 80. IBA Group Description and Business Overview
Table 81. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 82. IBA Group Radiopharmaceutical Product
Table 83. IBA Group Recent Developments/Updates
Table 84. GE Healthcare Corporation Information
Table 85. GE Healthcare Description and Business Overview
Table 86. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 87. GE Healthcare Radiopharmaceutical Product
Table 88. GE Healthcare Recent Developments/Updates
Table 89. China Isotope & Radiation Corporation Information
Table 90. China Isotope & Radiation Description and Business Overview
Table 91. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 92. China Isotope & Radiation Radiopharmaceutical Product
Table 93. China Isotope & Radiation Recent Developments/Updates
Table 94. Jubilant Pharma Corporation Information
Table 95. Jubilant Pharma Description and Business Overview
Table 96. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 97. Jubilant Pharma Radiopharmaceutical Product
Table 98. Jubilant Pharma Recent Developments/Updates
Table 99. Eli Lilly Corporation Information
Table 100. Eli Lilly Description and Business Overview
Table 101. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 102. Eli Lilly Radiopharmaceutical Product
Table 103. Eli Lilly Recent Developments/Updates
Table 104. Advanced Accelerator Applications Corporation Information
Table 105. Advanced Accelerator Applications Description and Business Overview
Table 106. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 107. Advanced Accelerator Applications Radiopharmaceutical Product
Table 108. Advanced Accelerator Applications Recent Developments/Updates
Table 109. SIEMENS Corporation Information
Table 110. SIEMENS Description and Business Overview
Table 111. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 112. SIEMENS Radiopharmaceutical Product
Table 113. SIEMENS Recent Developments/Updates
Table 114. Dongcheng Corporation Information
Table 115. Dongcheng Description and Business Overview
Table 116. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 117. Dongcheng Radiopharmaceutical Product
Table 118. Dongcheng Recent Developments/Updates
Table 119. Navidea Corporation Information
Table 120. Navidea Description and Business Overview
Table 121. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 122. Navidea Radiopharmaceutical Product
Table 123. Navidea Recent Developments/Updates
Table 124. Production Base and Market Concentration Rate of Raw Material
Table 125. Key Suppliers of Raw Materials
Table 126. Radiopharmaceutical Distributors List
Table 127. Radiopharmaceutical Customers List
Table 128. Radiopharmaceutical Market Trends
Table 129. Radiopharmaceutical Market Drivers
Table 130. Radiopharmaceutical Market Challenges
Table 131. Radiopharmaceutical Market Restraints
Table 132. Global Radiopharmaceutical Sales Forecast by Type (2023-2028) & (M Doses)
Table 133. Global Radiopharmaceutical Sales Market Share Forecast by Type (2023-2028)
Table 134. Global Radiopharmaceutical Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 135. Global Radiopharmaceutical Revenue Market Share Forecast by Type (2023-2028)
Table 136. Global Radiopharmaceutical Sales Forecast by Application (2023-2028) & (M Doses)
Table 137. Global Radiopharmaceutical Sales Market Share Forecast by Application (2023-2028)
Table 138. Global Radiopharmaceutical Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 139. Global Radiopharmaceutical Revenue Market Share Forecast by Application (2023-2028)
Table 140. Global Radiopharmaceutical Sales Forecast by Region (2023-2028) & (M Doses)
Table 141. Global Radiopharmaceutical Sales Market Share Forecast by Region (2023-2028)
Table 142. Global Radiopharmaceutical Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 143. Global Radiopharmaceutical Revenue Market Share Forecast by Region (2023-2028)
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Radiopharmaceutical
Figure 2. Global Radiopharmaceutical Market Share by Type in 2021 & 2028
Figure 3. Actinium-225 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Radium-223 Product Picture
Figure 6. Holmium-166 Product Picture
Figure 7. Other Product Picture
Figure 8. Global Radiopharmaceutical Market Share by Application in 2021 & 2028
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Global Radiopharmaceutical Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Radiopharmaceutical Market Size (2017-2028) & (US$ Million)
Figure 14. Global Radiopharmaceutical Sales (2017-2028) & (M Doses)
Figure 15. Radiopharmaceutical Sales Share by Manufacturers in 2021
Figure 16. Global Radiopharmaceutical Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Radiopharmaceutical Players: Market Share by Revenue in 2021
Figure 18. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Radiopharmaceutical Sales Market Share by Region (2017-2022)
Figure 20. Global Radiopharmaceutical Sales Market Share by Region in 2021
Figure 21. Global Radiopharmaceutical Revenue Market Share by Region (2017-2022)
Figure 22. Global Radiopharmaceutical Revenue Market Share by Region in 2021
Figure 23. U.S. Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. China Taiwan Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. U.A.E Radiopharmaceutical Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Radiopharmaceutical by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Radiopharmaceutical
Figure 49. Manufacturing Process Analysis of Radiopharmaceutical
Figure 50. Radiopharmaceutical Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Radiopharmaceutical Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......

Global Radiopharmaceuticals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138

According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......

Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 137

According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......

Global Radiation Dose Management Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Landauer - Sectra AB - Afga-Gevaert - INFINITT Healthcare - Bayer Healthcare - PACSHealth - Koninklijke Philips - GE Healthcar......

Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 111

Market Overview of Global Radiation Dose Management market: According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years. The radiation dose management channel includes information of radiation dose recording software, real-ti......

Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124

Report Overview: The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period. This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......

Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 133

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Nov-2023        Price: US 3380 Onwards        Pages: 116

Market Overview of Global Radiopharmaceutical market: According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs